Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who ...

Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a ...

A contrast MRI can help doctors identify any active lesions ... Learn more about the early signs and symptoms of MS. During an MS flare, doctors can prescribe steroids to help reduce inflammation ...

Current conventional imaging will continue to impact our daily care of MS patients for years to come. Better guidelines related to undesirable disease activity seen on MRI will need to be ...

Currently, patients with clinically isolated syndrome (CIS) and brain lesions on MRI suggestive of multiple sclerosis (MS), are offered a confirmatory MRI scan after 6 months. Researchers in Italy ...

most important value of PEMF therapy in MS is to decrease inflammation. If you get enough inflammation, you get enough tissue damage, you get what's called plaque. And that's why you do the MRI ...

Reich, M.D., Ph.D., both at NIH’s National Institute of Neurological Disorders and Stroke (NINDS), combined repeated MRI imaging with brain-tissue analysis, including gene expression, to track the ...

In May 2016, Siemens' healthcare arm rebranded itself as Siemens Healthineers to establish itself as a mainstream digital health player. Since then, the company's biggest venture came in October ...